The Pharmacopoeia is a book containing directions for the identification of compound medicines. The role of the European pharmacopoeia consists in helping to protect the public health throughout Europe by focusing on the quality of the medicine and its compounds.
One of the steps in the protection of the public health is pesticide residue analysis on the raw materials of the compounds of these medicines. Primoris is able to analyze these raw materials.
Unless otherwise indicated in the monograph, the herbal drug to be examined at least complies with the limits indicated in table 2.8.13.-1 of the European Pharmacopoeia.
Analyzing pesticide residues on commodities of vegetal origin which are used in the composition of medication, is part of the protection of public health.
As a specialized laboratory, Primoris works together with producers and international organizations to provide reliable analysis methods which aresupporting the needs of the medicinal market.
Are you active in the medical sector and interested in our services, don’t hesitate to contact us.
Proficiency tests, independent controls of a laboratory’s analysis quality, are part of Primoris’ everyday operation. The past months Primoris participated in the following proficiency tests.
UPDATE 10 January 2022 | Belgium is currently dealing with the fifth wave of the coronavirus because of the omicron variant. For the moment, this new wave has no impact on our activities and we will do everything within our power to ensure the continuity of our services to our customers.
The analytical method QU2 is a challenging analysis to execute in a high-quality way. Thanks to our daily strive for quality and the highest reliability, we will be able to offer, as of Monday 23 August, the QU2 method under accreditation for fruit, vegetables, oilseeds and cereals.
Using state-of-the-art technology is a definite must if you want to offer the highest reliability in terms of analytical results, speed and service. Thanks to daily investments and the use of the newest technology, we will lower the reporting limit on 18 June for a number of components included in our multiresidue methods and we will also add a number of components to our scope: